TRPV3 (Transient Receptor Potential Vanilloid 3) is a calcium-permeable ion channel belonging to the TRP vanilloid subfamily, primarily expressed in epithelial tissues, including skin, oral/nasal mucosa, and the gastrointestinal tract. It functions as a sensor for warmth (32–39°C), chemical ligands, and mechanical stimuli, playing roles in thermoregulation, skin barrier maintenance, itch, and pain signaling. Dysregulation of TRPV3 is linked to skin disorders (e.g., Olmsted syndrome, pruritus), chronic inflammation, and neuropathic pain, making it a therapeutic target.
TRPV3 antibodies are laboratory-generated tools (polyclonal or monoclonal) designed to detect, quantify, or modulate TRPV3 protein expression and activity. These antibodies are critical for techniques like Western blotting, immunohistochemistry, and immunofluorescence, enabling researchers to map TRPV3 distribution in tissues, study its activation/inhibition mechanisms, or assess its involvement in disease models. Specificity is validated using knockout controls or competitive assays. Some antibodies are engineered to block channel function, aiding in mechanistic studies or drug discovery.
Research applications span basic science (e.g., understanding TRPV3’s role in signal transduction) and translational studies (e.g., evaluating its potential as a biomarker or therapeutic target). Challenges include ensuring antibody selectivity due to homology among TRP channels. Continued development of high-affinity, isoform-specific TRPV3 antibodies remains vital for advancing studies on sensory biology, inflammatory pathways, and targeted therapies.